Open AccessEffectiveness of Sofosbuvir and Daclatasvir in treatment of Hepatitis-C: An experience of tertiary care hospital in Karachi
Author(s) -
Nazish Butt,
Anoshia Saleem,
Muhammad Ali Khan,
Ali Akbar
Publication year - 2021
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.37.7.4627
Subject(s) - medicine , daclatasvir , sofosbuvir , cirrhosis , regimen , gastroenterology , ribavirin , chronic hepatitis , hepatitis c , observational study , virology , virus
To assess the effectiveness of Sofosbuvir (SOF) and Daclatasvir (DCV) in patients with chronic hepatitis C (CHC), compensated cirrhosis (CC) and decompensated cirrhosis (DCLD) either treatment naïve or experienced.